Finance

Lists
FBLG:NASDAQ
Fibrobiologics Inc
1,81 $
+2,84%
(+0,050) 1D
1,75 $
-3,31% (-0,060)
After hours
Closed: 4 սեպ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for FBLG...
Open
1,73 $
High
1,90 $
Low
1,71 $
Mkt. cap
12,05 մլն
Avg. vol.
297,90 հզր
Volume
210,46 հզր
52-wk high
12,40 $
52-wk low
0,62 $
EPS
-5,74 $
Shares outstanding
6,66 մլն
No. of employees
15
Open
1,73 $
High
1,90 $
Low
1,71 $
Mkt. cap
12,05 մլն
Avg. vol.
297,90 հզր
Volume
210,46 հզր
52-wk high
12,40 $
52-wk low
0,62 $
EPS
-5,74 $
Shares outstanding
6,66 մլն
No. of employees
15
News stories
From web sources and news partners
About Fibrobiologics Inc
CEO-
Employees15
Founded2021
HeadquartersՀյուստոն, Տեխաս, Միացյալ Նահանգներ
Sector-
Websitefibrobiologics.com
Analyst ratings
Based on 1 analyst giving stock ratings to FBLG in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for FBLG in the last 3 months
Highest
Current 1,81 $
6,00 $ (+231,49%)
Average
6,00 $ (+231,49%)
Lowest
6,00 $ (+231,49%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Caufield
H.C. Wainwright
Buy
Maintained
6,00 $
+231,5%
08/04/2026
Michael Okunewitch
Maxim Group
Hold
Downgraded
-
-
05/04/2026
Jason Kolbert
D. Boral Capital
Hold
Downgraded
-
-
03/26/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2,79 մլն
797,00 հզր
2,95 մլն
1,66 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,25 մլն
1,79 մլն
2,12 մլն
2,38 մլն
Operating expense
5,04 մլն
2,59 մլն
5,07 մլն
4,03 մլն
Total operating expenses
5,04 մլն
2,59 մլն
5,07 մլն
4,03 մլն
Operating income
-5,04 մլն
-2,59 մլն
-5,07 մլն
-4,03 մլն
Other non operating income
-813,00 հզր
-475,00 հզր
54,00 հզր
-92,00 հզր
EBT including unusual items
-5,78 մլն
-3,24 մլն
-5,00 մլն
-4,12 մլն
EBT excluding unusual items
-5,78 մլն
-3,24 մլն
-5,00 մլն
-4,12 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5,78 մլն
-3,24 մլն
-5,00 մլն
-4,12 մլն
Net profit margin
-
-
-
-
Earnings per share
-2,60
-0,60
-1,33
-0,66
Interest and investment income
73,00 հզր
25,00 հզր
20,00 հզր
15,00 հզր
Interest expense
-
-204,00 հզր
-4,00 հզր
-7,00 հզր
Net interest expenses
73,00 հզր
-179,00 հզր
16,00 հզր
8,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-4,97 մլն
-2,52 մլն
-5,00 մլն
-3,97 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps